Belpointe Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Belpointe Asset Management's DGX Position: Q3 2026 in Review
Belpointe Asset Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 5,688 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #442.
Belpointe Asset Management first reported a position in DGX in Q3 2018 and has held it in 17 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Belpointe Asset Management held 5,688 shares of Quest Diagnostics worth $1.33M as of Q3 2026.
- Belpointe Asset Management left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up 0.04% of Belpointe Asset Management's portfolio in Q3 2026, its #442 holding.
- Belpointe Asset Management first reported a position in Quest Diagnostics in Q3 2018 and has held it in 17 quarters since.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Belpointe Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.